Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe/Simvastatin vs Atorvastatin in Type 2 Diabetes
NCT00541697Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Jan 2005
- Primary completion
- Sep 2005
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of ezetimibe and simvastatin in hypercholesterolemia (3 arms), sponsored by Organon & Co. Primary endpoint: Low Density Lipoprotein Cholesterol at 6 weeks. Started Jan 2005; status: completed.
02
Drugs
ezetimibesimvastatin
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00541697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00541697.